SAB Biotherapeutics is advancing a new class of immunotherapies with targeted, fully human polyclonal antibodies for the treatment of Covid-19, diabetes, organ transplant & flu.
Xeris Pharmaceuticals
3 followers
Cosette Pharmaceuticals
1 follower
Bristol-Myers Squibb
278 followers
NYU Langone Health
35 followers
West Pharmaceutical Services
11 followers
Curia Global
8 followers
AbbVie
305 followers
Navitus Health
6 followers
Corcept Therapeutics
4 followers
Catalyst Pharmaceuticals
3 followers
Arthritis Knee Pain Centers
2 followers